Evidence map›Paper›PMID 41284177›Full record

Trial reportJournal of prevention (2022)2026

Drug Use Prevention in Low-income Neighborhoods of Montevideo-Uruguay: the Effectiveness of Mantente REAL in Public Elementary Schools.

Flavio F Marsiglia, Carlos Libisch, Stephen S Kulis, Paul Ruiz

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of prevention (2022), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Flavio F MarsigliaGlobal Center for Applied Health Research, Arizona State University, Phoenix, AZ, USA. marsiglia@asu.edu.ORCID http://orcid.org/0000-0002-5622-3620
Carlos LibischFacultad de Psicología, Universidad de la República, Montevideo, Uruguay.
Stephen S KulisGlobal Center for Applied Health Research, Arizona State University, Phoenix, AZ, USA.
Paul RuizFacultad de Veterinaria, Universidad de la República, Montevideo, Uruguay.

Funding

Arizona State University NA
6 · The paper itself

Abstract

This article reports on the effectiveness of the drug use prevention program Mantente REAL (MREAL) with elementary school students in Uruguay. MREAL is the Spanish language version of Original Program, an internationally validated program recognized as an efficacious universal intervention for youth drug use prevention. In partnership with selected elementary schools, a binational team of investigators implemented and evaluated a linguistically and culturally adapted version of MREAL in Montevideo, Uruguay. The sample included 223 sixth-grade students from six public schools located in low-income neighborhoods. The students' regular classroom teachers implemented the intervention after receiving a two-day training. Schools were randomly assigned into experimental and control conditions and all consented students, regardless of condition, completed a pre- and post-test survey. Compared to control school students, those receiving MREAL reported significant desired effects for cigarette use, marijuana/hard drug use, drug use personal norms, and drug offers from peers. Findings indicated that MREAL is a promising program for preventing drug use in Uruguay elementary schools with similar socioeconomic characteristics. The article concludes with a set of policy, practice and future research implications and recommendations for the further advancement of evidence-based universal prevention in Uruguay.

Indexed as

School Health ServicesSubstance-Related DisordersChildFemaleHumansMalePovertyProgram EvaluationSchoolsStudentsUruguayDrug useElementary schoolPreventionUruguay

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.